Vitamin D receptor polymorphisms and the polycystic ovary syndrome: A systematic review
January 2017
in “Journal of Obstetrics and Gynaecology Research”
TLDR The review found no clear link between vitamin D receptor gene variations and polycystic ovary syndrome.
The document is a systematic review of studies exploring the association between vitamin D receptor (VDR) polymorphisms and polycystic ovary syndrome (PCOS). The review, which included 11 studies published between 2009 and 2015, found inconsistent results. Some studies reported associations between specific VDR polymorphisms and PCOS or related traits like insulin resistance, while others found no significant associations. For example, the 'CC' genotype of the FokI polymorphism was linked to an increased risk for insulin resistance and higher serum insulin levels. The review also noted that certain genotypes might be associated with PCOS severity or metabolic parameters, such as BMI and testosterone levels. However, the overall evidence did not conclusively link VDR polymorphisms with PCOS risk or severity. The review concluded that more research is needed to fully understand the relationship between VDR polymorphisms and PCOS, and it suggested that vitamin D levels might have a more significant impact on PCOS features than VDR polymorphisms, with vitamin D supplementation potentially beneficial in managing PCOS symptoms.
View this study on obgyn.onlinelibrary.wiley.com →
Cited in this study
research The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report
The report concludes that PCOS is mainly a condition of excess male hormones and its definition may change as new information is discovered.
research Polycystic ovary syndrome
PCOS is a complex condition with major health impacts, needing more research for better diagnosis and treatment.
Related
research Vitamin D receptor polymorphisms and the polycystic ovary syndrome: A systematic review
The review found no clear link between vitamin D receptor gene variations and polycystic ovary syndrome.